Brian H Yang
Healthcare Journalist Covers China, and Japan for Over a Decade
Brian is a veteran biotech and medtech journalist covering rising innovation in China, Japan's biopharma, and U.S.-China health policies. Brian Yang has written extensively on biopharma R&D, regulatory, clinical, market access, and commercial strategy. Brian has led a team of writers to produce industry-leading coverage in the world’s second-largest healthcare market.
Portfolios
Policy, Regulations
Will US Clinical Study Diversity Guidance Cloud Chinese Firms’ Prospects For Going Global?'We Are Not Waiting To Be Replaced': Medical Affairs Pros Take On GPT-4oCan BIOSECURE Maintain Its Virality In The TikTok Era?US FDA Asked To Tighten China Risk Control By Legislators As Markup LoomsChina Implements Data Transfer Regulation, With Some WaiversChina Regulatory Overreach Prompts Concerns For FDA Inspections, InnovationChina Regulation in Year Of The Dragon: Good Distribution Practice, Corporate Law, Export BansChina’s Regulator Has New Head But Will He Advance Further Reforms?Pricing, Reimbursement
Legend Buyout Report Boosts, Validates China BiotechFosun To Fully Acquire Henlius In Go-Global Push?China VBP, Localization And Other Strategies - How Far And Which Way?China HPV Demand Shaping Merck But Competitors Catching UpChina‘s Demographic Double Whammy: Newborns Decline, Medical Insurance Funding ShrinkingConnect with me on social media
Enhance your global healthcare coverage
In Search of top-notch pharma writing and editing services? Look no further than Brian Yang - your trusted expert on biopharma and the healthcare industry!